A PYMNTS Company

US: DOJ investigates potential antitrust issues in McKesson-Change merger

By  |  September 7, 2016

The Department of Justice appears to be looking into potential antitrust concerns regarding the proposed merger between McKesson and Change Healthcare.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The two companies announced in June plans to combine McKesson’s IT business unit with Change Healthcare’s businesses to create a new company focused on healthcare technology and technology-enabled services.

    According to McKesson’s Form 8-K filing with the Securities and Exchange Commission, the company received a request from the DOJ Aug. 31 for additional information and documentation regarding the proposed sale as related to the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

    The companies do not appear to be worried that the sale will be derailed. “McKesson and Change Healthcare will respond as quickly as practicable and continue to work cooperatively with the DOJ staff in connection with its review of the transactions contemplated in the Contribution Agreement. Both McKesson and Change Healthcare continue to expect the transaction to be completed in the first half of the calendar year 2017,” according to the filing.

    Full Content: Beckers Hospital Review

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.